ERRANTE, FOSCA
 Distribuzione geografica
Continente #
NA - Nord America 1.593
AS - Asia 1.142
EU - Europa 1.020
SA - Sud America 182
AF - Africa 24
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.975
Nazione #
US - Stati Uniti d'America 1.553
CN - Cina 340
RU - Federazione Russa 329
SG - Singapore 284
IT - Italia 278
HK - Hong Kong 152
BR - Brasile 139
KR - Corea 96
VN - Vietnam 88
FR - Francia 54
PL - Polonia 54
IE - Irlanda 51
SE - Svezia 49
DE - Germania 48
IN - India 46
ES - Italia 36
BD - Bangladesh 32
GB - Regno Unito 32
ID - Indonesia 31
CA - Canada 24
JP - Giappone 24
FI - Finlandia 21
CH - Svizzera 18
NL - Olanda 16
AR - Argentina 14
AU - Australia 13
MX - Messico 11
AT - Austria 10
CO - Colombia 8
CL - Cile 6
JO - Giordania 6
UZ - Uzbekistan 6
EC - Ecuador 5
IL - Israele 5
NG - Nigeria 5
TH - Thailandia 5
ZA - Sudafrica 5
IQ - Iraq 4
TR - Turchia 4
BO - Bolivia 3
DK - Danimarca 3
EG - Egitto 3
MM - Myanmar 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
RE - Reunion 3
UA - Ucraina 3
VE - Venezuela 3
BE - Belgio 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HN - Honduras 2
KE - Kenya 2
LT - Lituania 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GR - Grecia 1
GT - Guatemala 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.975
Città #
Santa Clara 437
Singapore 227
Ashburn 199
Dallas 152
Hong Kong 139
Hefei 100
Seoul 91
Florence 75
Dublin 47
San Jose 47
Chandler 45
Beijing 38
The Dalles 36
Council Bluffs 35
Milan 34
Warsaw 34
New York 32
Ho Chi Minh City 30
Los Angeles 28
Hanoi 26
Rome 26
Fairfield 25
North Charleston 24
Paris 23
Buffalo 22
Lauterbourg 22
São Paulo 20
Moscow 19
Tokyo 19
Jakarta 17
Kent 16
Madrid 16
Bern 14
Hangzhou 14
Houston 14
Woodbridge 14
Chicago 12
Lappeenranta 11
Seattle 11
Wilmington 11
Bengaluru 10
Guangzhou 10
Munich 10
Naples 10
Vienna 10
Ann Arbor 9
Helsinki 9
Melbourne 9
Portsmouth 9
San Diego 9
Shanghai 9
West Lafayette 9
Boston 8
Cambridge 8
Orem 8
Princeton 8
Salt Lake City 8
Toronto 8
Frankfurt am Main 7
Lawrence 7
Oklahoma City 7
Rio de Janeiro 7
Altamura 6
Bologna 6
Tashkent 6
Cagliari 5
Chennai 5
Da Nang 5
Dearborn 5
Denver 5
London 5
Montreal 5
Mumbai 5
Stockholm 5
Yubileyny 5
Atlanta 4
Boardman 4
Bogotá 4
Brooklyn 4
Dong Ket 4
Düsseldorf 4
Johannesburg 4
Memphis 4
Phoenix 4
Poplar 4
San Francisco 4
Somerville 4
Sydney 4
Wroclaw 4
Abuja 3
Ahmedabad 3
Amsterdam 3
Austin 3
Benifaió 3
Brasília 3
Brescia 3
Clifton 3
Curitiba 3
Detroit 3
Edinburgh 3
Totale 2.548
Nome #
Therapeutic proteins immunogenicity: a peptide point of view 515
Bioactive peptides and compositions comprising them / Peptidi bioattivi e composizioni che li contengono 261
Peptides as Active Ingredients: a Challenge for Cosmeceutical Industry 230
Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy 223
Anti-adalimumab antibodies purified from juvenile idiopathic arthritis patients: kinetic characterization among biosimilars 209
Serpin A1 and the modulation of type I collagen turnover: effect of the C-terminal peptide 409-418 (SA1-III) in human dermal fibroblasts 203
Biomaterial Inks from Peptide-Functionalized Silk Fibers for 3D Printing of Futuristic Wound-Healing and Sensing Materials 190
Influence of the modification of the cosmetic peptide Argireline on the affinity toward copper(II) ions 181
Peptide-Functionalized Silk Fibers as a Platform to Stabilize Gelatin for Use in Ingestible Devices 180
Serpins’ role in skin treatment: structure, active fragments and mechanism of inhibition 164
Progettazione, sintesi e valutazione biologica di peptidi bioattivi: modulatori del turnover del collagene per uso cosmeceutico e antigeni del virus SARS-CoV-2 per uso diagnostico e vaccinale. Design, synthesis, and biological evaluation of bioactive peptides: collagen turnover modulators for cosmeceutical use and SARS-CoV-2 virus antigens for diagnostic and vaccinal uses. 162
Peptide and peptidomimetic tyrosinase inhibitors 158
Retro-inverso collagen modulator peptide derived from Serpin A1 with enhanced stability and activity in vitro 156
Susceptibility of cosmeceutical peptides to proteases activity: Development of dermal stability test by LC-MS/MS analysis 155
Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas 152
A SARS–CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients 150
Development of a retro-inverso tetrapeptide collagen modulator as anti-aging active principle 143
null 134
Adalimumab and anti-adalimumab antibodies a novel method of detection and quantification in human sera based on surface plasmon resonance technique 132
Development of bioactive peptides of cosmetic interest through environmentally sustainable processes 111
Development of bioactive peptides of cosmetic interest through environmentally sustainable processes 107
Quantitative evaluation of adalimumab and anti-adalimumab antibodies in sera using a surface plasmon resonance biosensor 70
Peptide and peptidomimetic tyrosinase inhibitors 26
APPLICATION OF 2D-CHROMATOGRAPHY FOR THE DETECTION OF COSMETIC PEPTIDES IN SKIN HOMOGENATES 2
Totale 4.014
Categoria #
all - tutte 9.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/202285 2 2 5 5 4 9 3 6 2 9 18 20
2022/2023211 16 30 15 12 11 39 28 13 17 2 10 18
2023/2024207 4 11 17 11 29 23 19 36 4 17 16 20
2024/20251.272 32 89 58 137 300 207 47 100 56 63 97 86
2025/20262.087 235 329 272 213 231 55 177 87 113 107 99 169
Totale 4.014